2022 annual financial data
BriaCell Therapeutics 2022 Operating margin
BriaCell Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -15,288,941 USD and net income was -26,838,903 USD.
Operating cash flow was -12,484,376 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,288,941 USD
- Net income
- -26,838,903 USD
- Operating cash flow
- -12,484,376 USD